O-185 Overcoming hypothesized antagonism with intermittent...

Lung Cancer 2005 / 7 Vol. 49

O-185 Overcoming hypothesized antagonism with intermittent dosingof erlotinib in combination with docetaxel (DOC) in non-small cell lung cancer (NSCLC): A phase I study

Davies, A., Lara, P., Lau, D., Mack, P., Gumerlock, P., Gandara, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80319-8
Date:
July, 2005
File:
PDF, 322 KB
english, 2005
Conversion to is in progress
Conversion to is failed